OPDP’s first enforcement letter of 2025 sent to Dexcel over multiple myeloma drug exhibit
Regulatory NewsMichael Mezher
Advertising, Promotion and LabelingEnforcementUnited StatesRegulatory NewsMichael MezherAdvertising, Promotion and LabelingEnforcementUnited States